Skip to content
healthcare.dev
Get a free key

Daliresp

NDC 0310-0095, roflumilast, tablet, from AstraZeneca Pharmaceuticals LP.

Product NDC
0310-0095
Status
Listed
Labeler
AstraZeneca Pharmaceuticals LP
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA022522
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0095 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ROFLUMILAST500 ug/1

Pharmacologic classes

Phosphodiesterase 4 Inhibitor [EPC]; Phosphodiesterase 4 Inhibitors [MoA]

Package NDCNDC-11Package
0310-0095-300031000953030 TABLET in 1 BOTTLE, PLASTIC (0310-0095-30)
0310-0095-900031000959090 TABLET in 1 BOTTLE, PLASTIC (0310-0095-90)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c9a1d0a8-581f-4f91-a2b8-f419192d0ebf

  • NADAC price for package 00310009530

    GET /v1/drugs/nadac/00310009530

  • NADAC price for package 00310009590

    GET /v1/drugs/nadac/00310009590

Use it

Look up 0310-0095 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0310-0095 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0310-0095. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.